QUILYPSO Trademark

Trademark Overview


On Monday, October 21, 2019, a trademark application was filed for QUILYPSO with the United States Patent and Trademark Office. The USPTO has given the QUILYPSO trademark a serial number of 79274098. The federal status of this trademark filing is IR CANCELLED - US REGISTRATION CANCELLED as of Wednesday, September 21, 2022. This trademark is owned by Novartis AG. The QUILYPSO trademark is filed in the Pharmaceutical Products category with the following description:

Anti-infectives; anti-inflammatories; antibacterial pharmaceuticals; antibiotics; antifungal preparations; antivirals; cardiovascular pharmaceuticals; dermatological pharmaceutical preparations; inhaled pharmaceutical preparations for the prevention and treatment of respiratory diseases and disorders; pharmaceutical preparations acting on the central nervous system; pharmaceutical preparations and substances for the prevention and treatment of gastro-intestinal diseases; pharmaceutical preparations for the prevention and treatment of diseases and disorders of the autoimmune system, the metabolic system, the endocrine system, the musculo-skeletal system and the genitourinary system; pharmaceutical preparations for use in hematology and in tissue and organ transplantation; pharmaceutical preparations for the prevention and treatment of eye diseases and conditions; pharmaceutical preparations for the prevention and treatment of heart rhythm disorders; pharmaceutical preparations for the p...
quilypso

General Information


Serial Number79274098
Word MarkQUILYPSO
Filing DateMonday, October 21, 2019
Status404 - IR CANCELLED - US REGISTRATION CANCELLED
Status DateWednesday, September 21, 2022
Registration Number6132689
Registration DateTuesday, August 25, 2020
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, June 9, 2020

Trademark Statements


Goods and ServicesAnti-infectives; anti-inflammatories; antibacterial pharmaceuticals; antibiotics; antifungal preparations; antivirals; cardiovascular pharmaceuticals; dermatological pharmaceutical preparations; inhaled pharmaceutical preparations for the prevention and treatment of respiratory diseases and disorders; pharmaceutical preparations acting on the central nervous system; pharmaceutical preparations and substances for the prevention and treatment of gastro-intestinal diseases; pharmaceutical preparations for the prevention and treatment of diseases and disorders of the autoimmune system, the metabolic system, the endocrine system, the musculo-skeletal system and the genitourinary system; pharmaceutical preparations for use in hematology and in tissue and organ transplantation; pharmaceutical preparations for the prevention and treatment of eye diseases and conditions; pharmaceutical preparations for the prevention and treatment of heart rhythm disorders; pharmaceutical preparations for the prevention and treatment of immune system related diseases and disorders; pharmaceutical preparations for the prevention and treatment of kidney diseases; pharmaceutical preparations for the prevention and treatment of diabetes; pharmaceutical preparations for the prevention and treatment of hypertension; pharmaceutical preparations for the prevention and treatment of skin disorders; pharmaceutical preparations for use in dermatology; pharmaceutical preparations for use in urology; pharmaceutical preparations for ophthalmological use; pharmaceutical preparations for the prevention and treatment of cancer and tumors; pharmaceutical preparations for the prevention and treatment of allergies; pharmaceutical preparations for the prevention and treatment of bone diseases; pharmaceutical preparations for the prevention and treatment of respiratory diseases and asthma

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status CodeH - NOT AVAILABLE
Class Status DateWednesday, September 21, 2022
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameNovartis AG
Party Type30 - Original Registrant
Legal Entity Type25 - NOT AVAILABLE
AddressCH

Party NameNovartis AG
Party Type20 - Owner at Publication
Legal Entity Type25 - NOT AVAILABLE
AddressCH

Party NameNovartis AG
Party Type10 - Original Applicant
Legal Entity Type25 - NOT AVAILABLE
AddressCH

Trademark Events


Event DateEvent Description
Monday, April 17, 2023NOTIFICATION OF EFFECT OF CANCELLATION OF INTL REG E-MAILED
Monday, April 17, 2023DEATH OF INTERNATIONAL REGISTRATION
Saturday, January 23, 2021FINAL DECISION TRANSACTION PROCESSED BY IB
Friday, December 11, 2020GENERIC MADRID TRANSACTION SENT TO IB
Friday, December 11, 2020GENERIC MADRID TRANSACTION CREATED
Wednesday, November 25, 2020FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Tuesday, August 25, 2020REGISTERED-PRINCIPAL REGISTER
Tuesday, June 9, 2020OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, June 9, 2020PUBLISHED FOR OPPOSITION
Wednesday, May 20, 2020NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Thursday, May 7, 2020APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, April 15, 2020TEAS/EMAIL CORRESPONDENCE ENTERED
Tuesday, April 14, 2020CORRESPONDENCE RECEIVED IN LAW OFFICE
Tuesday, April 14, 2020TEAS RESPONSE TO OFFICE ACTION RECEIVED
Friday, February 14, 2020REFUSAL PROCESSED BY IB
Wednesday, January 29, 2020ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Wednesday, January 29, 2020TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Saturday, January 25, 2020NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Friday, January 24, 2020REFUSAL PROCESSED BY MPU
Sunday, December 29, 2019NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Saturday, December 28, 2019NON-FINAL ACTION WRITTEN
Monday, December 23, 2019ASSIGNED TO EXAMINER
Saturday, December 21, 2019APPLICATION FILING RECEIPT MAILED
Tuesday, December 17, 2019NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Monday, December 16, 2019LIMITATION FROM ORIGINAL APPLICATION ENTERED
Thursday, December 12, 2019SN ASSIGNED FOR SECT 66A SUBSEQ DESIG FROM IB